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CORRECTION
A transcription factor network specifying inhibitory versus
excitatory neurons in the dorsal spinal cord
Mark D. Borromeo, David M. Meredith, Diogo S. Castro, Joshua C. Chang, Kuang-Chi Tung, Francois Guillemot
and Jane E. Johnson
There was an error in the ePress version of Development 141, 2803-2812 (posted 12 June 2014).
On p. 9, the accession number for the RNA-Seq data should read GSE55831.
The print and final online versions are correct.
The authors apologise to readers for this mistake.
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A transcription factor network specifying inhibitory versus
excitatory neurons in the dorsal spinal cord
Mark D. Borromeo1, David M. Meredith1,*, Diogo S. Castro2, Joshua C. Chang1, Kuang-Chi Tung1,
Francois Guillemot3 and Jane E. Johnson1,‡
ABSTRACT
The proper balance of excitatory and inhibitory neurons is crucial for
normal processing of somatosensory information in the dorsal spinal
cord. Two neural basic helix-loop-helix transcription factors (TFs),
Ascl1 and Ptf1a, have contrasting functions in specifying these
neurons. To understand how Ascl1 and Ptf1a function in this process,
we identified their direct transcriptional targets genome-wide in the
embryonic mouse neural tube using ChIP-Seq and RNA-Seq. We
show that Ascl1 andPtf1a directly regulate distinct homeodomain TFs
that specify excitatory or inhibitory neuronal fates. In addition, Ascl1
directly regulates genes with roles in several steps of the neurogenic
program, including Notch signaling, neuronal differentiation, axon
guidance and synapse formation. By contrast, Ptf1a directly regulates
genes encoding components of the neurotransmitter machinery in
inhibitory neurons, and other later aspects of neural development
distinct from those regulated by Ascl1. Moreover, Ptf1a represses the
excitatory neuronal fate by directly repressing several targets of
Ascl1. Ascl1 and Ptf1a bind sequences primarily enriched for a
specific E-Box motif (CAGCTG) and for secondary motifs used by
Sox, Rfx, Pou and homeodomain factors. Ptf1a also binds sequences
uniquely enriched in the CAGATG E-box and in the binding motif for
its co-factor Rbpj, providing two factors that influence the specificity of
Ptf1a binding. The direct transcriptional targets identified for Ascl1
and Ptf1a provide a molecular understanding of how these DNA-
binding proteins function in neuronal development, particularly as key
regulators of homeodomain TFs required for neuronal subtype
specification.
KEY WORDS: ChIP-Seq, bHLH transcription factor, Dorsal neural
tube, Neuronal subtype specification, Mouse, Chick, Ascl1, Ptf1a
INTRODUCTION
The neurons within the dorsal spinal cord provide the initial
integration for somatosensory information originating from the
periphery. These neurons relay sensory information to local spinal
cord neurons and higher brain centers to modulate and coordinate
the appropriate physiological response to environmental stimuli
(Liu and Ma, 2011; Ross, 2011). The proper processing of
somatosensory information requires the correct balance of
excitatory and inhibitory neurons within the dorsal spinal cord.
Revealing the genetic programs that give rise to these different
classes of neurons will provide insight into neuronal disorders as
well as address fundamental concepts in transcriptional control of
cell fate determination and neuronal subtype specification.
Specification of excitatory and inhibitory neurons in the developing
nervous system relies on combinations of transcription factors (TFs) to
activate or repress specific neurogenic programs. The basic helix-
loop-helix (bHLH) and homeodomain (HD) families of TFs are
particularly important in generating the correct number and subtypes
of neurons in the dorsal spinal cord (Cheng et al., 2004, 2005;
Glasgow et al., 2005; Gowan et al., 2001; Gross et al., 2002; Helms
et al., 2005;Mizuguchi et al., 2006;Muller et al., 2005;Wildner et al.,
2006). In the dorsal neural tube, multiple progenitor domains can be
identified by neural bHLH factors, such as Ascl1 (previouslyMash1)
and Ptf1a (Glasgow et al., 2005; Gowan et al., 2001; Helms et al.,
2005). Genetic studies have shown that in the absence of one bHLH
factor, the neural progenitor cells take on the identity of the
neighboring cells, resulting in the transfating of one neuronal type
to another. For example, loss of Ptf1a results in a loss of GABAergic
neurons and excess glutamatergic neurons in the spinal cord dorsal
horn (Glasgow et al., 2005). By contrast, Ascl1 has the opposite
effect and is necessary and sufficient for generation of early-born
glutamatergic neurons (Chang et al., 2013; Helms et al., 2005;
Mizuguchi et al., 2006; Nakada et al., 2004). Robust disruption inHD
factor expression is reported as a primary phenotype in Ascl1 and
Ptf1a mutants. Many HD factors, such as Pax2 and Tlx3, have been
shown to be essential for continued specification of the neuronal
subtypes (Batista and Lewis, 2008; Cheng et al., 2004, 2005; Gross
et al., 2002; Huang et al., 2008; Pillai et al., 2007). Given the temporal
and genetic relationship between bHLH and HD factors, HD factors
are prime candidates for being direct transcriptional targets of the
bHLH factors in the dorsal spinal cord.
Ptf1a and Ascl1 are Class II bHLH TFs that bind the degenerate
DNA motif CANNTG (E-box) as heterodimers with E-proteins,
and activate transcription (Beres et al., 2006; Nakada et al., 2004).
For decades, researchers have tried to understand how bHLH
factors can select and regulate their specific gene targets, given that
they bind similar degenerate E-box motifs in vitro [reviewed by
Bertrand et al. (2002); Lai et al. (2013)]. With advances in
chromatin immunoprecipitation (ChIP) and the increasing number
of identified cis-regulatory elements that are under the control of
bHLH factors, a preference for binding certain E-boxes in vivo has
been shown, thus explaining some of the functional specificity
(Fong et al., 2012; Klisch et al., 2011; Lai et al., 2011; Meredith
et al., 2013; Seo et al., 2007). Additional influences on specificity
probably involve the epigenetic landscape (Fong et al., 2012;
Meredith et al., 2013) and the pool of transcriptional co-factors that
are available in a given population of progenitors (Lai et al., 2013).
However, Ptf1a and Ascl1 are co-expressed in a subset of neural
progenitors, and thus, although they function in a similar cellular
environment, they have distinct activities in neuronal specification.Received 15 November 2013; Accepted 15 May 2014
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Here, we address a fundamental concept in transcriptional control
of cell fate determination by probing how these two related TFs
select and regulate distinct neurogenic programs in vivo.
Performing ChIP-Seq and RNA-Seq experiments using mouse
neural tube tissue, we identify genes that are directly regulated by
Ascl1 and Ptf1a. We demonstrate that Ascl1 and Ptf1a activate a
glutamatergic or GABAergic specification program by directly
regulating distinct subsets of HD factor genes. Additional targets
were identified for Ascl1 consistent with its role in regulating
several aspects of neurogenesis, whereas targets for Ptf1a illustrate
its role in regulating genes encoding components of inhibitory
neuron neurotransmitters and synapses. These distinct targets for
Ascl1 and Ptf1a reflect differences in the timing of their function,
with Ascl1 being expressed earlier during neurogenesis than Ptf1a.
The specificity of Ascl1 and Ptf1a function is explained, at least in
part, through differential preferences of DNA-binding sequences, as
well as by direct and indirect repression of several Ascl1-activated
targets by Ptf1a.
RESULTS
Ascl1 and Ptf1a bind largely distinct sites within neural tube
chromatin and have distinct E-box sequence preferences
In the dorsal spinal cord, progenitor cells transiently express Ascl1
in the ventricular zone (Fig. 1A,B). As these cells begin to
differentiate, a subset of these now postmitotic cells express Ptf1a
as they migrate laterally toward the mantle zone (Fig. 1A-B00).
Thus, overlap of Ptf1a and Ascl1 expression can be found in a
subpopulation of the developing dorsal spinal cord near the
ventricular and mantle zone border. The progenitor cells,
expressing Ascl1 alone, or with the subsequent expression of
Ptf1a, result in the activation of different TFs and neuronal fates in
the spinal cord (Fig. 1C) (Glasgow et al., 2005; Nakada et al., 2004).
In order to uncover mechanisms by which two neural class II bHLH
factors regulate different sets of gene programs that give rise to
distinct subtypes of neurons in the dorsal neural tube, we compared
and contrasted the genome-wide binding sites of Ascl1 and Ptf1a by
ChIP-Seq in E12.5 mouse neural tubes. ChIP-Seq for Ascl1 and
Ptf1a have been recently published (Meredith et al., 2013; Sun et al.,
2013), but were re-evaluated here and compared using the peak-
calling software Homer (Heinz et al., 2010). Using the parameters of
a false discovery rate (FDR) cutoff of 0.001, a 4-fold enrichment of
sequence tags in the target experiment over control and a cumulative
Poisson P-value threshold of 0.0001, Ascl1 was found to bind 4082
sites and Ptf1a was found at 7749 sites, with 1588 of those sites
bound by both factors (Fig. 2A; supplementary material Table S1).
Heat maps show the binding profiles of Ascl1 and Ptf1a (Fig. 2A).
The stringent criteria for peak calling discard many low-affinity
Ptf1a- and Ascl1-binding events, and visual inspection of the heat
maps (Fig. 2A) suggests that the 1588 overlapping sites might be an
underestimate. Ascl1 and Ptf1a preferentially bind distal DNA
elements (>5-500 kb from transcription start sites) rather than
proximal promoters (Fig. 2B). Genes with Ascl1- or Ptf1a-bound
sites within 5 kb of their transcription start sites, and those with
multiple Ascl1 or Ptf1a sites, were expressed at higher mean levels
(P-values <0.05) (supplementary material Fig. S1).
De novo motif analysis (Heinz et al., 2010) of the Ascl1- and
Ptf1a-called peaks returned the canonical E-box (CANNTG)
(Fig. 2C), the known class II bHLH consensus-binding site
(Murre et al., 1989). We found that 98% of Ascl1- and 85% of
Ptf1a-bound sites contained a generic CANNTG E-box within
75 bp of the peak center. The specific primary E-box motifs show
that, whereas the CAGCTG E-box is enriched in both Ascl1- and
Ptf1a-bound sites, Ptf1a peaks are also enriched within the
CATCTG/CAGATG E-box (Fig. 2C). The primary E-box motifs
are commonly found near the peak centers (Fig. 2C,D), and on
average there are two or more E-boxes in each peak (supplementary
material Fig. S1). An example of a Ptf1a-bound site that is not
shared with Ascl1 is shown for the inhibitory neuronal specification
gene Pax2 (Fig. 2E). The DNA sequence under the summit of the
Ptf1a peak within Pax2 shows a highly conserved sequence that
contains a TC/GA core E-box. Additionally, the average Ascl1
binding is lowest at Ptf1a peaks that contain only a TC/GA core
E-box compared with Ptf1a peaks that have a GC core E-box
(Fig. 2F). A total of 1332 Ptf1a peaks were classified as peaks with a
TC/GA E-box only; among these sites, only 145 overlap with Ascl1
peaks. Thus, in vivo Ptf1a can bind DNA with GC or TC/GA
E-boxes; however, Ascl1 preferentially binds to regions with the GC
E-box. These results suggest that these two bHLH factors regulate
distinct gene expression programs through recognition of distinct
DNA binding motifs.
Enrichment of non-E-box transcription factor motifs within
Ascl1- and Ptf1a-bound genomic regions
The specific E-box sequence influences binding site selection, but
cooperation from additional TFs may also modulate Ascl1 and/or
Ptf1a binding. Therefore, we searched for additional sequence
motifs enriched within the regions bound by both Ptf1a and Ascl1
(Fig. 2G) and in peaks specific to Ascl1 or Ptf1a (Fig. 2H). We
found that sites shared by Ptf1a and Ascl1 are enriched with the GC
E-box, Sox, HD, Rfx and Pou motifs (Fig. 2G). In fact, regardless of
how the data are binned, shared sites, Ascl1 only or Ptf1a only are all
enriched for these motifs. Moreover, Ptf1a is a component of a
trimeric complex that includes Rbpj in addition to the heterodimeric
E-protein partner; this complex is required for Ptf1a function (Beres
et al., 2006; Hori et al., 2008; Masui et al., 2008). With over 1500
sites shared by Ptf1a and Ascl1, we anticipated an enrichment of
the Rbpj binding site. Indeed, embedded within the Rfx motif is the
canonical Rbpj binding site known as the TC-box (Fig. 2G,
Fig. 1. Ascl1 and Ptf1a overlap in the dorsal neural tube
cells. (A-B00) Immunofluorescence for Ascl1 and Ptf1a in
mouse E11.5 neural tube. Black dashed box in A marks the
magnified region in B-B00. Arrowheads indicate examples of
Ascl1 and Ptf1a colocalization. (C) A summary of the known TF
network involved in generating excitatory and inhibitory
populations in the dorsal spinal cord.
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underlined sequence). Thus, Rfx motifs could be bound by Rfx
factors, by Rbpj or by both.
In order to find motifs enriched specifically in the Ptf1a-bound
sites, we performed de novo motif analysis using all Ptf1a peaks,
but used Ascl1-bound sites as the background. This strategy
revealed the TC/GA core E-box and a stronger consensus
sequence for the Rbpj binding site than that found within peaks
shared by Ascl1 and Ptf1a (Fig. 2G,H). The highest frequency of
the Rbpj motif is found near the center of Ptf1a-bound sites (Ptf1a
only and shared), whereas Ascl1-only sites display a low
frequency of the motif (Fig. 2J). In the reciprocal de novo motif
analysis of Rbpj-binding sites from Rbpj ChIP-Seq of E12.5
neural tube (Meredith et al., 2013), the Rbpj motif is enriched
along with an E-box that is similar to the Ptf1a primary motif
(Fig. 2I). This is consistent with a role for Rbpj in influencing the
selection of Ptf1a binding.
Conversely, we searched for Ascl1-specific co-factors, using
Ascl1 peaks called and using Ptf1a sites as background. We did not
find any other transcription factor motifs enriched beyond the
preferential binding of Ascl1 to the GC core E-box (Fig. 2H). This
suggests that Ascl1-specific co-factor binding sites, if present, occur
at a low frequency and are not detected by this approach, or that
the co-factor shares a redundant motif with Ptf1a sites. Thus, the
primary distinction between Ascl1- and Ptf1a-bound regions is the
presence of the CAGATG/CATCTG E-box and a strong Rbpj
consensus motif in Ptf1a-bound regions. Furthermore, Sox, HD,
Pou and Rfx factors found with the E-box in these regions begin to
define potential motif combinations that suggest the presence of a
neural-specific enhancer.
We used a chick electroporation reporter assay to test the
requirement for E-box and Sox motifs for activity in two identified
enhancers (supplementary material Fig. S2). In both ePrdm13::
GFP (a Ptf1a target) and eTlx3::GFP (an Ascl1 target), enhancers
drive GFP expression in the dorsal neural tube, but requirement
for the E-box and Sox motifs was different for each motif in each
enhancer. For example, ePrdm13::GFP activity depends on the
Sox motif, but not on two CA E-box sites (supplementary material
Fig. S2D,E,I), whereas eTlx3::GFP activity depends on a GC E-
box, but not the Sox motif (supplementary material Fig. S2G,H,J).
Thus, enhancers identified through Ascl1 and/or Ptf1a binding
can activate transcription in the correct tissue, but transcription
factor motifs identified as enriched in the genomic data sets are
not consistently required for enhancer activity in these assays.
Ascl1 and Ptf1a have opposite actions in neuronal subtype
specification
It is well-established that Ascl1 and Ptf1a influence the expression
of several HD factors that mark specific neuronal populations and
function in the maturation of those neurons in the dorsal neural
tube [reviewed by Lai et al. (2013)]. To summarize prior studies
Fig. 2. Ptf1a- and Ascl1-binding sites in
the neural tube reveal distinct and
overlapping preferences. (A) Heat map of
ChIP-Seq signal intensity ±2.5 kb around
peak centers bound by Ascl1, Ptf1a or
both in E12.5 mouse neural tube.
(B) Distribution of bound sites with respect
to transcriptional start sites (TSS). (C) De
novo motif analysis. Density plots show the
primary motif enriched near the peak
center. (D) Distribution of E-box core type
found nearest to peak centers. (E) Example
of a Ptf1a-bound site, not shared by Ascl1,
located within the Pax2 gene. (F) Coverage
of Ascl1 ChIP-Seq fragments at Ptf1a peaks
that contain a GA/TC E-box only, a GC
E-box only or both GA/TC and GC E-boxes.
(G) De novo motif analysis shows that the
GC core E-box, Sox, Rfx/Rbpj and Pou/
homeobox motifs are enriched in sites
shared by Ptf1a and Ascl1. (H) Motifs
enriched in Ascl1 sites over Ptf1a, or in
Ptf1a sites over Ascl1. (I) Motif analysis of
Rbpj ChIP-Seq sites (from E12.5 neural
tube) identified the known Rbpj motif and a
Ptf1a-like E-box motif. (J) The frequency of
finding the Rbpj motif in Ascl1 only, Ptf1a
only or Ascl1/Ptf1a shared sites.
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that revealed the genetic network regulating neuronal subtype
specification in the E11.5 dorsal neural tube, and to introduce the
populations used in the current study for the ChIP-Seq and RNA-
Seq experiments, we show here the expression patterns of Ascl1
and Ptf1a and some of the HD factors that specify the excitatory
(Tlx1/3) and inhibitory (Pax2, Lhx1/5) neurons in the wild type
(WT) and mutants of Ascl1 and Ptf1a (Fig. 3).
The opposing functions of Ascl1 and Ptf1a in specifying
neuronal subtype in the dorsal neural tube are illustrated by the
changes in HD factor expression in Ascl1 and Ptf1a mutant mouse
embryos. The excitatory neuronal populations in the dorsal neural
tube (dI3, dI5 and dILB), marked by the HD factors Tlx1 and Tlx3
(Fig. 3G), are drastically reduced at E11.5 in the Ascl1 null
(Fig. 3H), whereas in the Ptf1a null they are markedly increased
(Fig. 3I). By contrast, inhibitory neuronal populations (dI4 and
dILA), marked by Pax2, Lhx1 and Lhx5 (Fig. 3J,M), are lost in the
Ptf1a null (Fig. 3L,O). These inhibitory markers are also
diminished in the Ascl1 null (Fig. 3K,N), a phenotype probably
secondary to the dependence of Ptf1a expression on Ascl1 at this
stage (Fig. 3E) (Mizuguchi et al., 2006). There are additional
complexities and feedback loops in the transcriptional network,
including repressive interactions of Tlx1/3 on Pax2 levels (Cheng
et al., 2005), and involvement of other TFs, such as Prdm13
(Chang et al., 2013) (see diagram Fig. 1C). In summary, Ascl1
and Ptf1a are at the head of a transcription factor network that is
crucial in generating the GABAergic (inhibitory) and
glutamatergic (excitatory) neuronal populations in the dorsal
spinal cord. As the HD factors are genetically downstream of the
bHLH factors, we hypothesized that they are direct transcriptional
targets of Ascl1 and Ptf1a in the dorsal spinal cord. In the
following sections, we provide evidence supporting this
hypothesis; we also identify a cohort of genes directly regulated
by Ascl1 and Ptf1a that allow these factors to direct neuronal
differentiation and neuronal subtype specification.
In order to identify the transcriptomes downstream of Ascl1 and
Ptf1a, we used fluorescence-activated cell sorting (FACS) to isolate
dorsal neural tube populations plus and minus Ascl1 and Ptf1a, and
performed RNA-Seq. For the Ascl1-lineage cells, we used
Ascl1GFP/+ knock-in embryos (Leung et al., 2007) compared with
Ascl1GFP/null embryos that completely lack Ascl1 protein. Because
GFP is more stable than Ascl1, Ascl1-expressing progenitor cells
and their immediate progeny were isolated in this paradigm
(supplementary material Fig. S3A). For the Ptf1a lineage, we
isolated cells from transgenic embryos in which mCherry is driven
by a 12.4 kb genomic region that directs expression to the dorsal
neural tube overlapping, but not restricted to, the Ptf1a-expression
domain (supplementary material Fig. S3B) (Meredith et al., 2009).
The 12.4kbPtf1a::mCherry line was crossed to the Ptf1aCre knock-
in mouse (Kawaguchi et al., 2002), and mCherry+ cells were
isolated from Ptf1a−/+ and Ptf1a−/− neural tubes. The identity
and purity of the samples was confirmed (supplementary material
Fig. S3C,D, see brackets).
RNA-Seq from the Ascl1 heterozygotes compared with the Ascl1
mutants identified 1173 genes with a significant difference in gene
expression (P-value <0.05), including 449 Ascl1-activated (higher in
heterozygotes than in nulls) and 724 Ascl1-repressed (lower in
heterozygotes than in nulls) (Fig. 3P, red dots in left panel).
Comparing Ptf1a-heterozygous cells with Ptf1a null cells revealed
361 genes showing a significant change in expression, including 132
Ptf1a-activated and 229 Ptf1a-repressed (Fig. 3P, red dots in right
Fig. 3. bHLH factors Ascl1 and Ptf1a have
opposite actions in neuronal subtype
specification in the developing spinal cord.
(A-O) Immunofluorescence for Ascl1, Ptf1a,
Tlx1/3, Pax2 and Lhx1/5 on mouse E11.5
neural tube from wild-type and Ascl1 or Ptf1a
null embryos. Brackets indicate where Ascl1
and Ptf1a are expressed and where
phenotypes are detected in the mutants. Red
indicates a marker of excitatory neurons, and
blue indicates markers of inhibitory neurons or
their precursors. Asterisk in O indicates a Ptf1a-
independent Lhx1/5+ population (dI2) that is
unaffected in the Ptf1a null. (P) RNA-Seq data
show transcript levels (FPKM) in Ascl1 lineage
cells from Ascl1 control or null embryos (left
plot), and Ptf1a lineage cells from Ptf1a control
or null embryos (right plot). Genes with a
significant change in expression in the mutants
versus controls are marked in red (P-value
<0.05). Genes above the diagonal are
repressed (Repr) and genes below the diagonal
are activated (Act). (Q) The number of genes
activated or repressed by Ptf1a or Ascl1.
(R) The total number of genes activated or
repressed by Ascl1 or Ptf1a, as determined by
RNA-Seq, and the number of genes that
contain an Ascl1- or Ptf1a-binding site
assigned by GREAT (McLean et al., 2010)
(black fill, direct targets).
2806
RESEARCH ARTICLE Development (2014) 141, 2803-2812 doi:10.1242/dev.105866
D
E
V
E
LO
P
M
E
N
T
panel). As expected, the HD TFs Tlx1, Tlx3 (Fig. 3P) and Lmx1b –
which mark excitatory neurons in the dorsal spinal cord – require
Ascl1 for expression, as detected by a significant decrease in their
transcript levels in the Ascl1 mutant versus Ascl1 heterozygous
populations. Conversely, Tlx1, Tlx3 and Lmx1b significantly increase
in the absence of Ptf1a (Fig. 3P and Fig. 4A; supplementary material
Table S2). Among the genes that require Ptf1a for expression are those
encoding the inhibitory neuronal markers Pax2, Lhx1 and Lhx5
(Fig. 3P and Fig. 4A; supplementary material Table S2). These
inhibitory neuronal markers also require Ascl1, as seen in the more
subtle decrease in Pax2, Lhx1 and Lhx5 in Ascl1 mutants (Fig. 3P
and Fig. 4A; supplementary material Table S2). These results are
consistent with the immunohistochemistry (Fig. 3A-O) and confirm
the robustness of these data.
The majority of genes that change when Ascl1 or Ptf1a are
mutated are non-overlapping, suggesting distinct functions for
these bHLH TFs (Fig. 3Q). However, the subset of Ptf1a-activated
genes that are also activated by Ascl1 include Pax2 and Lhx1/5
and distinctly define dI4/dILA Inhibitory neurons (32 genes,
supplementary material Table S4). Coregulation of these genes by
Ptf1a and Ascl1 may reflect the dependence of some Ptf1a
expression on Ascl1 (Fig. 3D,E). More strikingly, 63 of Ptf1a-
repressed genes are activated by Ascl1 (Fig. 3Q). This subset of
genes specifically marks the dI3/5, dILB neurons and includes
those encoding the HD factors Tlx1 and Tlx3 (Fig. 3G-I and
Fig. 4A). This group also contains genes that code for factors, such
as Cbln1 and Cbln2, which are involved in forming connections
that promote synapse formation in glutamatergic neurons (Cagle
and Honig, 2014; Ito-Ishida et al., 2012). Thus, genes activated by
Ascl1, but repressed by Ptf1a, define a subset of excitatory neurons
in the dorsal spinal cord (Fig. 3).
Homeodomain neuronal specification factors are direct
downstream targets of Ascl1 and Ptf1a
Direct downstream targets of Ascl1 and Ptf1a are enriched in
genes that influence neuronal subtype specification. We define
direct downstream targets here as genes that (1) show a significant
change of expression between controls and mutants, and (2) have
an Ascl1- or Ptf1a-binding site within the regulatory region of the
gene, as identified by the GREAT algorithm (McLean et al.,
2010). We identified 449 putative targets regulated directly by
Ascl1 (224 activated and 225 repressed). For Ptf1a, 207 putative
targets were identified (101 activated and 106 repressed)
(Fig. 3R). The high number of repressed genes predicted in this
analysis was unexpected, as Ascl1 and Ptf1a are primarily known
as transcriptional activators.
Fig. 4. Ascl1 and Ptf1a directly regulate the homeodomain factors
involved in neuronal specification. (A) Expression levels in dorsal
neural tubes of Ascl1 or Ptf1a control and mutant embryos of the HD
factor genes that are directly regulated by Ptf1a (left panel) or by Ascl1
(right panel). y-axis is in log10 scale. Directly activated targets of Ptf1a
partially depend on Ascl1 expression, whereas direct targets of Ascl1
are repressed by Ptf1a. All changes in gene expression are significant
(P-value <0.5), except Pax8 and Gbx2 in the Ascl1 null, and Isl1 and
Gsx2 in thePtf1a null. (B,C) Genomic regions around Ptf1a targets (B) or
Ascl1 targets (C) displaying Ascl1 (red track) and Ptf1a (blue track)
ChIP-Seq data. Binding sites called by Homer are indicated by tick
marks or an x (validated by qPCR) above each track. Beige box marks
sequences previously shown to drive dorsal neural tube expression
in transgenic animals (Chang et al., 2013; Meredith et al., 2013).
(B0,C0) ChIP-qPCR validating several Ptf1a- and Ascl1-binding sites
found in the ChIP-Seq assay. Kirrel2 andDll1 are known targets of Ptf1a
and Ascl1 (Castro et al., 2006; Henke et al., 2009; Meredith et al., 2013).
The number above each bar indicates the fold of enrichment found at
that site over the negative control (Kirrel2 open reading frame, orf ).
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We looked specifically for HD factor genes as direct targets
of the bHLH factors. We found that Ptf1a directly activates a set of
HD factor-encoding genes: Pax2, Lhx1, Pax8, Lhx5, Gbx1 and
Gbx2 (Fig. 4A-B0; supplementarymaterial Table S3).Most of these
are involved in development of the dorsal horn spinal cord
GABAergic neurons (John et al., 2005; Luu et al., 2011; Pillai et al.,
2007). By contrast, direct targets of Ascl1 comprise a different set
of HD factor genes: Tlx3, Tlx1, Lmx1b, Isl1, Gsx2, Pou3f1 and
Uncx (Fig. 4A,C,C0; supplementary material Table S3); some of
which contribute to the proper development of dorsal horn spinal
cord glutamatergic neurons (Avraham et al., 2010; Ding et al.,
2004; Mizuguchi et al., 2006; Zou et al., 2012). Most of these
Ascl1- and Ptf1a-binding sites identified by ChIP-Seq near the HD
factor genes were validated by ChIP-qPCR (Fig. 4B0,C0; see
supplementary material Fig. S4). Genomic regions containing the
Ptf1a sites near Lhx1 andPax2, and theAscl1 binding site nearTlx3
(Fig. 4B,C, peaks highlighted in beige), drive reporter activity in
the dorsal neural tube in transgenic animals (Chang et al., 2013;
Meredith et al., 2013), thereby validating their function.
It is striking that the HD factor genes directly activated by Ascl1
are defined as repressed by Ptf1a (Fig. 4A). The repression by Ptf1a
probably involves both direct and indirect mechanisms: there is no
binding of Ptf1a near genes such as Tlx1 and Gsx2 (suggesting
indirect mechanisms), but Ptf1a is found near Tlx3, Isl1, Lmx1b,
Uncx and Pou3f1 (suggesting direct mechanisms). Thus, Ascl1
directly activates a distinct set of HD factor genes for specifying the
glutamatergic lineage, and Ptf1a appears to directly and indirectly
repress this set of genes. Taken together, these findings indicate that
the bHLH factors Ascl1 and Ptf1a are at the head of a transcription
factor network controlling distinct subsets of HD factor genes
necessary for the generation of excitatory and inhibitory neurons in
the dorsal spinal cord.
Ascl1 directly regulates genes involved in multiple
processes of neurogenesis
Like other proneural bHLH factors, Ascl1 coordinates the
transition from a neural progenitor cell to a differentiated neuron,
which is reflected in the Gene Ontology (GO) analysis of Ascl1
targets (Bertrand et al., 2002; Wang et al., 2013) (Fig. 5;
supplementary material Table S5). This cellular transition
requires several processes to occur within a short window of
time, such as cell-cycle exit, cell migration and cell type-specific
gene expression. Indeed, Ascl1 directly regulates differentiation
and specification not only through the HD factors, but through a
larger complement of TFs (31 out of 224 activated target genes are
classified as encoding proteins with transcription factor activity;
Fig. 5C). Ascl1 also targets components of the Notch signaling
pathway, such as Dll1, Dll3, Mfng, Numbl and Hes5. Additional
aspects of neurogenesis regulated by Ascl1 include genes involved
in neuronal projection and axon guidance, such as Nfasc, Epha2,
Ephb3, Sema7a, Sema6b, Dcc, Plxna2, Pak3, Rgs3 and Slit.
Moreover, Ascl1 regulates several genes found in synaptic
terminals that regulate neurotransmitter release, such as Snap25
and Syt6. Notably, Ascl1 does not directly regulate genes involved
in generating or transporting the neurotransmitter glutamate, and
unlike the reported function for Ascl1 in the developing
telencephalon (Castro et al., 2011), in the caudal neural tube
Ascl1 does not activate many genes associated with proliferation.
Although Ascl1 is primarily known as an activator of
transcription, it appears to promote differentiation by repressing
neural stem maintenance genes, such as Sox2 and Pax3 (Nakazaki
et al., 2008; Pevny and Nicolis, 2010). In addition, Ascl1 represses
genes that function in early dorsal-ventral patterning of the spinal
cord, such asWnt1 (Augustine et al., 1995; Lee and Jessell, 1999)
and the sonic hedgehog pathway gene Gli3 (supplementary
material Table S5) (Persson et al., 2002). Ascl1 also represses
several genes involved broadly in differentiation of non-neuronal
lineages. The mechanisms by which Ascl1 represses transcription
are currently not yet understood.
Ptf1a represses the glutamatergic fate and directly
upregulates components of the GABAergic machinery
Similar to Ascl1, Ptf1a turns on a cascade of TFs that function in
neuronal differentiation and specification (Fig. 6A,E). Approximately
a quarter (24 out of 101) of Ptf1a-activated targets have transcriptional
activity. Ptf1a directly activates neural genes that are specific to the
GABAergic program, including genes encoding the TFs Prdm13,
Lhx1, Lhx5 and Pax2, which are important for maturation of these
neurons (Chang et al., 2013; Pillai et al., 2007). Nine of the target
genes encode synaptic proteins, such as Sv2c (Fig. 6D), Sez6 and
Iqsec3,which have all been shown to localize specifically at inhibitory
synapses (Fukaya et al., 2011; Gronborg et al., 2010; Gunnersen et al.,
2009). By contrast to Ascl1, Ptf1a activates genes involved in
GABA biosynthesis and transport pathways, such asGad1 (GAD67),
Abat (GABA transaminase), Slc32a1 (Viaat) and Slc6a5 (Glyt2)
(Fig. 6C-E). Additional Ptf1a-regulated genes contribute to the
extracellular matrix and to cell adhesion, such as Adamts4/20 and
Adamtsl1,Nrxn1, Vcan,Gpc3/4,Ccbe1,Nphs andKirrel2, or encode
subunits of voltage-gated calcium channels, such as Cacna2d2,
Cacna2d3 and Cacna1g.
Ptf1a not only activates genes necessary for the GABAergic
lineage, but also represses genes involved in the glutamatergic fate.
Approximately one-third (33 out of 106) of the genes repressed by
Fig. 5. Ascl1 directly regulates several components of the neurogenic
program in the developing spinal cord. (A,B) GO/KEGG of direct Ascl1-
activated (A) or Ascl1-repressed (B) targets. The colors denote the GO
category or KEGG pathway the terms were derived from, and the adjacent
numbers indicate the number of target genes in that category. (C) Summary of
Ascl1 gene targets involved in different steps of the neurogenic program. For a
complete list of Ascl1 target genes see supplementary material Table S3.
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Ptf1a are directly activated by Ascl1, notably HD factors Tlx3 and
Lmx1b (Fig. 4; supplementary material Table S3). Ptf1a has
recently been shown to indirectly repress the glutamatergic fate
through the activation of the target gene Prdm13 that interacts with
Ascl1 to block its transcriptional activity (Chang et al., 2013). Thus,
inhibition of Ascl1 targets by Ptf1a could be explained through this
indirect mechanism. However, the ChIP-Seq revealed that Ascl1
and Ptf1a commonly occupy the same genomic regions around 22
of 33 Ascl1-activated, Ptf1a-repressed genes, suggesting Ptf1a
repression of the glutamatergic fate might also involve direct
binding by Ptf1a.
DISCUSSION
Over two decades of research have established the genetic
requirement for neural bHLH TFs in generating the correct
number and composition of neurons in the central nervous
system. However, a mechanistic understanding of bHLH factor
function is only just emerging, as transcriptional targets are
beginning to be identified through genome-wide strategies
utilizing ChIP-Seq. In this study, we identify numerous direct
transcriptional targets of two bHLH factors in the mouse dorsal
neural tube. Ascl1 and Ptf1a provide an informative model pair of
factors for uncovering how two related TFs function to specify
distinct cell fates from a common progenitor domain. We show that
Ascl1 and Ptf1a directly activate sets of genes encoding HD factors
that are known specifiers of the glutamatergic or GABAergic
neuronal fates, respectively. In addition, Ptf1a represses many of
the Ascl1-activated HD genes, ensuring that the glutamatergic
phenotype is repressed in GABAergic neurons. Furthermore, Ascl1
targets genes early in the differentiation process, whereas Ptf1a
targets genes required for the activity of GABAergic neurons, thus
reflecting the temporal difference in their expression and the
fundamental differences in their function. The list of target genes for
Ptf1a and Ascl1 in the developing neural tube generated by this
study will serve as a rich dataset for further probing the functions of
these essential TFs (supplementary material Table S3).
Multiple mechanisms for crossrepression of Ascl1 and Ptf1a
in neuronal subtype specification
Through identifying HD factor genes as direct targets of Ascl1 and
Ptf1a, our current studies have provided mechanistic insights into
fundamental processes of cell fate determination, specifically those
generating the balance of excitatory and inhibitory neurons in the
dorsal spinal cord. Experiments testing the function of Ascl1 and
Ptf1a have shown that eachwill induce one cell fatewhile suppressing
the other (Chang et al., 2013;Glasgowet al., 2005;Helms et al., 2005;
Hori et al., 2008). Because Ascl1 and Ptf1a are known as
transcriptional activators, identifying the HD genes that function in
specifying the relevant neurons as direct targets of these bHLH
factors provides a simple model for generation of the excitatory and
inhibitory neurons, respectively. However, it is much less clear how
the alternative cell fates are repressed. Our results provide multiple
insights into possible mechanisms for this crossrepression.
Understanding how Ascl1 can repress the Pax2-defined
GABAergic lineages stems from our data showing that Ascl1
directly activates Tlx1 and Tlx3, and from previous studies that
demonstrated the crossrepression between the Tlx factors and Pax2
(Cheng et al., 2005). Tlx1 or Tlx3 suppress the GABAergic fate by
antagonizing the ability of the HD factor Lbx1 to induce Pax2
expression (see diagram Fig. 1C). Thus, the higher the levels of Tlx1
and Tlx3 driven by Ascl1, the lower the levels of Pax2. Consistent
with this indirect mechanism for Ascl1 suppression of the Pax2
GABAergic lineage, Ascl1 did not directly suppress Ptf1a-activated
target genes, as determined by ChIP-Seq. Instead, we found that
several of the Ptf1a-activated genes were also activated by Ascl1.
Taken together, it appears that Ascl1 activates the glutamatergic
lineage through direct regulation of HD factors such as the Tlx1/3
genes, but only indirectly represses the opposing lineage.
By contrast, Ptf1a appears to use both direct and indirect
mechanisms for suppressing the glutamatergic neuronal fate. We
recently identified Prdm13 as a direct downstream target of Ptf1a
that provides an indirect mechanism for Ptf1a suppression of the
glutamatergic fate (Chang et al., 2013). In this case Prdm13,
Fig. 6. Ptf1a directly opposes Ascl1
target genes and activates several
components of the GABAergic
machinery. (A,B) GO/KEGG of Ptf1a-
activated (A) or Ptf1a-repressed (B) targets
The colors denote the GO category or
KEGG pathway the terms were derived
from, and the adjacent numbers indicate
the number of target genes in that category.
(C) ChIP-Seq around Ptf1a target genes
involved in GABA biosynthesis and GABA/
glycine transport. Binding sites called by
Homer are indicated by tick marks above
each track. (D) Ptf1a target genes that are
specifically found in inhibitory presynaptic
terminals (in parentheses). (E) Summary of
Ptf1a gene targets involved in different
steps of inhibitory neuron specification. For
a complete list of Ptf1a target genes see
supplementary material Table S3.
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induced by Ptf1a, directly suppresses Ascl1 activity in inducing its
targets, such as Tlx1 and Tlx3 (see diagram Fig. 1C). In addition, we
show here that Ptf1a may suppress several Ascl1 targets directly,
although the specific mechanism used is unclear. In several cases,
Ptf1a binds near Ascl1-activated genes through sites that do not
overlap with Ascl1 sites (i.e. Tlx3, Uncx and Pou3f1). This would
suggest a mechanism by which Ptf1a recruits a transcriptional
repressor and blocks Ascl1 activity from a distant site; a capability
that has never been shown for Ptf1a. In other cases, such as binding
around Lmx1b, Ascl1 and Ptf1a locate to the same genomic site.
This suggests that competition might occur between Ptf1a and
Ascl1. Consistent with this possibility, Ptf1a has been found to
suppress the ability of Ascl1 to activate an E-box reporter in a
transcription assay (Obata et al., 2001). Given that Ptf1a and Ascl1
can bind a common CAGCTG E-box in vivo, Ptf1a could compete
with Ascl1 for these E-boxes and passively block Ascl1 activity, as
the Ptf1a/E-protein heterodimer is a poor activator (Beres et al.,
2006). Taken together, Ptf1a may deploy several mechanisms to
ensure the proper repression of a subset of Ascl1 target genes, thus
resulting in repression of glutamatergic lineage genes in the
GABAergic neurons.
Ascl1 and Ptf1a bind neuronal enhancers enriched with
specific transcription factor motifs
Ptf1a- and Ascl1-bound genomic regions in vivo are enriched with
multiple transcription factor family motifs, such as Sox, Pou, HD
and Rfx. Members of these families have been shown to play
important roles during neuronal development (Ashique et al., 2009;
Bergsland et al., 2011; Castro et al., 2006; Lodato et al., 2013). In
addition, de novo motif analysis of Sox2 and Brn2 (a Pou factor)
ChIP-Seq regions from cultured neural progenitor cells found
enrichment of the same set of motifs (Sox, Pou, HD, Rfx and E-box)
plus NFI (Lodato et al., 2013). Thus, combinations of these motifs
are emerging as indicators of a possible neural specific enhancer.
Different motif combinations have been reported in other cell
lineages, such as for macrophage-specific enhancers (Pu.1, C/EBP
and AP1) (Heinz et al., 2010, 2013) or for muscle lineage enhancers
(E-box, AP1, Meis, Runx and SP1) (Cao et al., 2010). We found no
significant space constraints between the DNA recognition motifs
across 150 bp, consistent with a presumptive collaborative binding
to select enhancers that would not necessarily require direct protein-
protein interactions between the different TFs. We tested the
requirement for the E-box and Sox motifs in active enhancers bound
by Ascl1 and Ptf1a, and found that their presence was necessary in
one case but in not the other. This illustrates our inability to predict
a motif required for enhancer activity in reporter assays, and
highlights the need for additional approaches to test the importance
of any given transcription factor motif. For example, the motif may
have been used to open or close chromatin at different stages within
the lineage progression than the stage being tested in a reporter assay
(Heinz et al., 2010; Stergachis et al., 2013).
Ptf1a binds a distinct E-box to regulate its specification
program
Ascl1 and Ptf1a ChIP-Seq data have provided valuable insight into
how two bHLH factors can regulate select target genes. Motif
analysis from these data shows that Ptf1a binds a common E-box
with Ascl1 (CAGCTG), but also has a preference for a distinct
E-Box (CATCTG/CAGATG). Other genome-wide studies have
shown that bHLH factors, such as Atoh1 and Neurod2, have an
E-box preference similar to Ptf1a (GC and TC/GA cores) (Fong
et al., 2012; Klisch et al., 2011; Lai et al., 2011). Interestingly,
E-box preferences for a specific bHLH factor can change depending
on the cell context; for example, Ptf1a in the developing pancreas
preferentially binds E-boxes with GC and GG/CC cores, but not the
TC/GA core preference found in the neural tube (Meredith et al.,
2013). Several studies have suggested that E-box binding by bHLH
factors is heavily dictated by the availability of the site; the
chromatin landscape of each tissue type would thus strongly
influence the target selection of a transcription factor (Fong et al.,
2012; Meredith et al., 2013). In this study, both Ascl1 and Ptf1a are
functioning in a similar chromatin landscape, yet sequence
preferences were still detected. Examination of the genes near
Ptf1a binding sites that contain just the specific GA/TC core E-box
alone revealed 41 out of 101 Ptf1a-activated genes, and include
known specification factors, such as Pax2 (Fig. 2E), Pax8, Lhx5,
Gbx2 and Prdm13. Thus, Ptf1a preference for a specific E-box,
distinct from Ascl1, is probably an important mechanism in
activating genes for the GABAergic neuronal identity and function.
MATERIALS AND METHODS
Mouse strains
Ptf1aCre ( p48Cre) was used as the Ptf1a null (Kawaguchi et al., 2002);
12.4Ptf1a::mCherry transgenic mice were used for isolation of Ptf1a
lineage cells from E11.5 WT or Ptf1a null neural tubes (Meredith et al.,
2009). Ascl1GFP (Ascl1tm1Reed/J) (Leung et al., 2007) was used for isolation
of Ascl1 lineage cells from E11.5 control or Ascl1 null (Guillemot et al.,
1993) neural tubes. PCR genotyping was performed as described (Glasgow
et al., 2005; Kim et al., 2007; Meredith et al., 2009). All procedures on
animals follow NIH Guidelines and were approved by the UT Southwestern
Institutional Animal Care and Use Committee.
In ovo chick electroporation and GFP measurement
Fertilized white Leghorn eggs from the Texas A&M Poultry Department
(College Station, USA) were incubated at 37°C for 48 h until stage HH12-13
(Hamburger and Hamilton, 1992). Supercoiled plasmid DNA (1 μg/μl each)
was injected into the lumen of the closed neural tube, and embryos were
electroporated as described (Timmer et al., 2001). After 48 h incubation at
37°C, stage HH24-25 embryos were processed for immunofluorescence or
GFP intensity quantification.
Immunofluorescence and tissue processing
Mouse E11.5 embryos and chick HH24-25 were processed as previously
described (Chang et al., 2013). Immunofluorescence was performed using
the following primary antibodies: rabbit anti-Ascl1 [1:10,000; J.E.J. group,
generated from bacterially expressed rat Ascl1 (aa 1-232)], guinea pig anti-
Ptf1a (1:5000; J.E.J. group-generated) (Hori et al., 2008), rabbit anti-Pax2
(1:1000; Life Technologies, 71-6000), rabbit anti-Tlx1/3 (1:20,000; gift
from T. Müller and C. Birchmeier, Max-Delbrück-Center for Molecular
Medicine, Berlin, Germany), mouse anti-Lhx1/5 (1:100; Developmental
Studies Hybridoma Bank, 4F2) and mouse anti-myc (1:100, ATCC, CRL-
1729). Fluorescence imaging of upper limb level sections was carried out on
a Zeiss LSM 510 confocal microscope.
ChIP-Seq
Detailed descriptions of Ptf1a, Rbpj (Meredith et al., 2013) and Ascl1
(Castro et al., 2011) E12.5 NT ChIP protocols have previously been
published. Ptf1a antibody (5 µg; Santa Cruz, sc-69320X) was used for
ChIP-qPCR validation. All ChIP-Seq samples are available on the GEO
database. For the Ptf1a ChIP-Seq sample (GSM1150324), we used the
telencephalon Ptf1a ChIP-Seq sample (GSM1347011) as control, as the
telencephalon is a neural tissue of similar developmental stage that does
not express Ptf1a. Both Rbpj (GSM1150327) and Ascl1 (GSM1347006)
ChIP-Seq samples were compared with their respective E12.5 neural tube
input (GSM1150340 and GSM1347007).
Sequence reads were mapped to the mm9 genome assembly with Bowtie
(Trapnell et al., 2009). Only unique reads were included and were
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normalized to 10 million reads. Peak calling was performed by HOMER
(annotatePeaks.pl - size 5000 -hist 10 -ghist) (Heinz et al., 2010) using an
FDR cutoff of 0.001. An additional cutoff of a cumulative Poisson P-value
of <0.0001 and a 4-fold enrichment of normalized sequenced reads in the
treatment sample over the control/input sample were used. A common
binding site between two samples was called when the peak summits of each
sample were found within 150 bp of each other.
mRNA isolation and sequencing (RNA-Seq)
Neural tubes from the 12.4kbPtf1a::mCherry;Ptf1aCre/+, 12.4kbPtf1a::
mCherry;Ptf1aCre/Cre, Ascl1GFP/+ or Ascl1GFP/− lines were dissociated in
DMEM/F12 with 0.25% trypsin, and GFP or mCherry positive cells were
purified by FACS. Total RNA was purified with a Mini RNA Isolation Kit
(Zymo). An mRNA-Seq kit (Illumina) was used for mRNA (polyA)
isolation and sequencing library preparation.
RNA-Seq data are available on the GEO database (GSE55831).
Sequence reads were aligned to the mm9 genome assembly using TopHat
v2.0.9 (Trapnell et al., 2009). All default settings were used except ‘-G
option’ and ‘–no-novel-juncs’. If a biological replicate was available, it
was specified and used to build an expression level model determined by
the FPKM method of Cuffdiff v2.1.1 (Trapnell et al., 2013, 2010). The
options used were multiple read correction (-u) and the bias correction
(-b). A gene was considered to be expressed if it had an FPKM >1. For a
gene to be called as differentially expressed, it required a P-value <0.05.
Scatter plots and expression bar plots were created by Cummerbund
(Trapnell et al., 2012).
GO classification and ChIP-Seq peak gene annotation
Distance to gene and gene annotations for ChIP-Seq peaks were obtained
using GREAT v1.82 (McLean et al., 2010). GREAT assigns a gene to a
binding region if the region falls within 5 kb 50 or 1 kb 30 of the transcription
start site (basal region), with a maximum extension of 1000 kb in either
direction. If the binding region falls within the basal region of multiple
genes, then more than one assignment is made. All parameters were left at
their default settings. Webgestalt (Wang et al., 2013) at default settings was
used for GO and KEGG pathway analysis.
Motif discovery and density plots
All tests for motif discovery were conducted with the HOMER package
v4.2, using the following settings: -size 150 – S 10 – bits using 150 bp
around each peak summit (Heinz et al., 2010). All Ascl1- or Ptf1a-binding
sites limited to 150 bp around each peak summit were used for de novo
analysis. HOMER uses a hypergeometric statistical analysis to determine
motif enrichment, using a random background sequence with similar GC
content to the test sample. To find the Ascl1 or Ptf1a factor-specific motifs,
all Ascl1 or Ptf1a peaks were used as the treatment, whereas the peak regions
not being tested were specified as the background. When searching for
transcription factor motifs, no mismatches to the motif matrix were allowed.
The E-box and Rbpj motif density plots were generated in HOMER
(annotatePeaks.pl –size 1000 –hist 10).
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